文献速递神经肿瘤

微小RNA-1231通过调控EGFR/PI3K/AKT轴在胶质瘤中发挥抑癌作用

MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
PubMed 文献 · J Neurooncol · 2018-05-17

该研究通过微阵列分析158例胶质瘤组织样本的miRNA表达,并用qRT-PCR检测miR-1231在胶质瘤与健康脑组织中的水平。体外实验使用miR-1231模拟物、抑制剂及靶向EGFR的siRNA,结合流式细胞术、CCK-8和集落形成实验评估增殖与细胞周期。双荧光素酶报告实验验证EGFR为miR-1231直接靶点,皮下GBM模型显示miR-1231过表达抑制肿瘤生长。

要点

  • miR-1231在胶质瘤组织中表达降低,且与EGFR水平呈负相关。
  • miR-1231下调与胶质瘤患者临床分期呈负相关。
  • miR-1231过表达抑制胶质瘤细胞增殖并在裸鼠模型中抑制肿瘤生长。

核心结论

  • EGFR是miR-1231的直接靶点,miR-1231/EGFR轴可能成为恶性胶质瘤未来有用的诊断靶点。

研究设计与样本

  • 研究对158例胶质瘤组织样本进行微阵列分析评估miRNA表达水平,并用qRT-PCR检测胶质瘤样本与健康脑组织中miR-1231水平。
  • 体外分析使用miR-1231模拟物、抑制剂及靶向EGFR的siRNA,采用流式细胞术、CCK-8实验和集落形成实验检测胶质瘤增殖与细胞周期。
  • 双荧光素酶报告实验检测miR-1231对EGFR的调控,并在皮下GBM模型中研究miR-1231上调的效果。

主要发现

  • miR-1231在人胶质瘤组织中表达降低,且与EGFR水平呈负相关。
  • miR-1231下调与人胶质瘤患者临床分期呈负相关。
  • miR-1231过表达显著下调胶质瘤细胞增殖,并在裸鼠模型中抑制肿瘤生长。
  • 生物信息学预测和荧光素酶实验证实EGFR是miR-1231的直接靶点。
  • EGFR过表达消除了miR-1231对PI3K/AKT通路的抑制作用和G1期阻滞。

临床怎么用

  • 作者认为miR-1231/EGFR轴可能成为恶性胶质瘤未来有用的诊断靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: MicroRNAs (miRNAs) have been shown to be involved in the initiation and progression of glioma. However, the underlying molecular mechanisms are still unclear. METHODS: We performed microarray analysis to evaluate miRNA expression levels in 158 glioma tissue samples, and examined miR-1231 levels in glioma samples and healthy brain tissues using qRT-PCR. In vitro analyses were performed using miR-1231 mimics, inhibitors, and siRNA targeting EGFR. We used flow cytometry, CCK-8 assays, and colony formation assays to examine glioma proliferation and cell cycle analysis. A dual luciferase reporter assay was performed to examine miR-1231 regulation of EGFR, and the effect of upregulated miR-1231 was investigated in a subcutaneous GBM model. RESULTS: We found that miR-1231 expression was decreased in human glioma tissues and negatively correlated with EGFR levels. Moreover, the downregulation of miR-1231 negatively correlated with the clinical stage of human glioma patients. miR-1231 overexpression dramatically downregulated glioma cell proliferation, and suppressed tumor growth in a nude mouse model. Bioinformatics prediction and a luciferase assay confirmed EGFR as a direct target of miR-1231. EGFR overexpression abrogated the suppressive effect of miR-1231 on the PI3K/AKT pathway and G1 arrest. CONCLUSIONS: Taken together, these results demonstrated that EGFR is a direct target of miR-1231. Our findings suggest that the miR-1231/EGFR axis may be a helpful future diagnostic target for malignant glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhang J, Zhang J, Qiu W, et al. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma. J Neurooncol. 2018. PMID: 29774498. doi:10.1007/s11060-018-2903-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。